Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?

Blood Res. 2021 Dec 31;56(4):333-334. doi: 10.5045/br.2021.2020322.

Authors

Emanuele Cencini¹, Alberto Fabbri¹, Donatella Raspadori¹, Alessandro Gozzetti¹, Monica Bocchia¹

Affiliation

¹ Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.

No abstract available

Publication types

Letter